Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT with or without ADT for oligometastatic prostate cancer (RADIOSA)
NCT03940235Phase 2Unknown
- Sponsor
- European Institute of Oncology
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in prostate cancer (PCa), sponsored by European Institute of Oncology. Status: unknown.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03940235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03940235.